What new opportunities does artificial intelligence offer for pharmaceuticals and biotech?

The Life Science Dialogue brings together stakeholders from the pharmaceutical, biotechnology, start-up, and scientific sectors in northern Germany to discuss the potential of artificial intelligence (AI) in the life sciences. We highlight the possible applications of AI, e.g., in the field of platform technologies, but also the legal and regulatory challenges involved in using AI in the life sciences industry.Join us and look forward to best practice examples from business, e.g., Pfizer, science, and the startup scene, political impetus, as well as time for networking and an evening program at the Institute for Solar System Research. The Life Science Dialogue is organized by Niedersachsen.next BioRegioN, Niedersachsen.next Startup, and the Chemical Industry Association of Northern Germany, in cooperation with the Association of Research-Based Pharmaceutical Companies, Pharma Deutschland, the German Pharmaceutical Industry Association, and the Max Planck Institute for Multidisciplinary Sciences.

We look forward to your participation!

Yours, Niedersachsen.next BioRegioN | Niedersachsen.next Startup | Verband Chemischer Industrie Landesverband Nord e.V. (VCI Nord)

In cooperation with: Verband Forschender Arzneimittelhersteller e.V. (VFA), Pharma Deutschland Region Nord, Bundesverband der Pharmazeutischen Industrie e.V. (BPI) Landesverband Nord

Brief information about the evening event: Speed dating is planned as part of the evening event, for which separate registration is required. The link will appear here shortly!